Xiaohua Wu

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Squamous Cell Carcinoma

Top Venues

JCO global oncology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

This page only lists publications with an associated author ORCID identifier.

Publications

Zheng Feng, Siyu Chen, Na An, Zhi-Hui Xiu, Xingzhu Ju, Xiaojun Chen, Rui Bi, Jie Wang, Shi-da Zhu, Xiaohua Wu, Hao Wen
Germline Mutational Landscape and Novel Targetable RAD51D Variant in Chinese Patients With Ovarian Cancer. JCO global oncology 10 (2024)
Zheng Feng, Siyu Chen, Na An, Zhi-Hui Xiu, Xingzhu Ju, Xiaojun Chen, Rui Bi, Jie Wang, Shi-da Zhu, Xiaohua Wu, Hao Wen
Germline Mutational Landscape and Novel Targetable RAD51D Variant in Chinese Patients With Ovarian Cancer. JCO global oncology 10 (2024)
Bradley J Monk, Antonio Gonzáles Martin, Lynn Buckley, Ursula A Matulonis, B J Rimel, Xiaohua Wu, Kathleen N Moore, Mansoor R Mirza
Safety and management of niraparib monotherapy in ovarian cancer clinical trials. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
Jin Li, Jianhua Yang, Huafeng Shou, Lin Zhang, Xiaohong Huang, Xuedong Tang, Fei Zheng, Fang Liu, Hao Wen, Huijuan Yang, Huaying Wang, Ziting Li, Xiaojun Chen, Xingzhu Ju, Xi Cheng, Jie Tang, Meiqin Zhang, Xiaohua Wu
Real-world outcomes of niraparib treatment in patients with ovarian cancer: a multicenter non-interventional study in China. Cancer communications (London, England) (2023)
Ning Li, Youzhong Zhang, Jing Wang, Jian Qing Zhu, Li Wang, Xiaohua Wu, Desheng Yao, Qiang Wu, Jihong Liu, Junying Tang, Rutie Yin, Ge Lou, Ruifang An, Guonan Zhang, Xiaoping Xia, Qingshui Li, Yaping Zhu, Hong Zheng, Xinfeng Yang, Yuanjing Hu, Xin Zhang, Min Hao, Yi Huang, Zhongqiu Lin, Dong Wang, Xiaoqing Guo, Shuzhong Yao, Xiaoyun Wan, Huaijun Zhou, Liangqing Yao, Xielan Yang, Heng Cui, Yuanguang Meng, Songling Zhang, Jing Qu, Ben Zhang, Jianjun Zou, Ling-Ying Wu
Fuzuloparib Maintenance Therapy in Patients With Platinum-Sensitive, Recurrent Ovarian Carcinoma (FZOCUS-2): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (22) (2022)
Qinhao Guo, Yong Wu, Hao Wen, Xingzhu Ju, Xiaohua Wu
Effect of the Number of Removed Lymph Nodes on Survival in Patients with FIGO Stage IB-IIA Cervical Squamous Cell Carcinoma following Open Radical Hysterectomy with Pelvic Lymphadenectomy: A Retrospective Cohort Study. Journal of oncology 2021 (2021)
Mengdong Ni, Jiajia Li, Hai-Yun Zhao, Fei Xu, Jingyi Cheng, Min Yu, Guihao Ke, Xiaohua Wu
BRD4 inhibition sensitizes cervical cancer to radiotherapy by attenuating DNA repair. Oncogene 40 (15) (2021)
Kathleen M Moore, Michael A Bookman, Jalid Sehouli, Austin Miller, Charles Anderson, Giovanni Scambia, Tashanna Myers, Cagatay Taskiran, Katina Robison, Johanna Maenpaa, Lyndsay Willmott, Nicoletta Colombo, Jessica Thomes-Pepin, Michalis Liontos, Michael A Gold, Yolanda Garcia, Sudarshan K Sharma, Christopher J Darus, Carol Aghajanian, Aikou Okamoto, Xiaohua Wu, Rustem Safin, Fan Wu, Luciana L Molinero, Vidya Maiya, Victor K Khor, Yvonne G Lin, Sandro Pignata
Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (17) (2021)
Yong Wu, Qinhao Guo, Xingzhu Ju, Zhixiang Hu, Lingfang Xia, Yu Deng, Ping Zhao, Meng Zhang, Yang Shao, Shengling Huang, Xiang-Huo He, Hao Wen, Xiaohua Wu
HNRNPH1-stabilized LINC00662 promotes ovarian cancer progression by activating the GRP78/p38 pathway. Oncogene 40 (29) (2021)